- About Us
- Services & Solutions
- Novel Technology Platform
- Bioconjugation Discovery
- Bioconjugation Process Development
- Analytical Development
- Formulation and DP Development
- GMP mAb Intermediate and Conjugation Manufacturing
- GMP Formulation, Fill and Lyophilization
- Payload and Linker R&D and Manufacturing
- Ready-Made Payloads & Linkers
- WuXi XDC Singapore Site
- Investor Relations
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Scientific Poster Download
Poster modified on 02/02/2026
Tool Enzymes Meet Antibody-Drug Conjugates
Speed and Performance through Specialized, Integrated Solutions
In oncology, speed to clinic is critical—yet access to high-purity, Current Good Manufacturing Practices (cGMP)-grade tool enzymes often slows progress. Many antibody-drug conjugate (ADC) programs rely on fragmented models that separate enzyme production from conjugation, adding risk and delay. WuXi XDC and WuXi Biologics integrate cGMP enzyme manufacturing with site-specific ADC conjugation into a single workflow, accelerating timelines while strengthening quality and regulatory alignment.
Download the white paper to step through enzyme-enabled ADC development supported by real-world data and examples.
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?